Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study

BACKGROUND: Neoadjuvant chemoradiotherapy is the treatment of choice in advanced rectal cancer, even though there are many patients who will not benefit from it. There are still no effective methods for predicting which patients will respond or not. The present study aimed to define the genomic prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinari, Chiara, Ballardini, Michela, Teodorani, Nazario, Giannini, Massimo, Zoli, Wainer, Emiliani, Ermanno, Lucci, Enrico, Passardi, Alessandro, Rosetti, Paola, Saragoni, Luca, Guidoboni, Massimo, Amadori, Dino, Calistri, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236016/
https://www.ncbi.nlm.nih.gov/pubmed/22099067
http://dx.doi.org/10.1186/1748-717X-6-161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236016/
https://www.ncbi.nlm.nih.gov/pubmed/22099067
http://dx.doi.org/10.1186/1748-717X-6-161

Ejemplares similares